BioNTech SE (BNTX) Revenue (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Revenue data on file, last reported at $1.1 billion in Q4 2025.

• In Q4 2025, Revenue fell 16.94% year-over-year to $1.1 billion; the TTM figure through Dec 2025 stood at $3.3 billion (up 15.35% YoY), while the FY2025 annual figure was $3.2 billion, up 2762.55% from the prior year.
• Revenue declined to $1.1 billion in Q4 2025, from $1.8 billion in the prior quarter.
• Across five years, Revenue topped out at $7.2 billion in Q3 2021 and bottomed at $35.3 million in Q2 2024.
• A 5-year average of $2.6 billion and a median of $1.5 billion in 2023 frame the typical range for Revenue.
• The widest YoY moves for Revenue: up 13797.8% in 2021, down 100.0% in 2021.
• Year by year, Revenue stood at $6.3 billion in 2021, then slumped by 31.03% to $4.4 billion in 2022, then sank by 63.54% to $1.6 billion in 2023, then dropped by 20.09% to $1.3 billion in 2024, then dropped by 16.94% to $1.1 billion in 2025.
• The last three Revenue figures came in at $1.1 billion (Q4 2025), $1.8 billion (Q3 2025), and $295.2 million (Q2 2025), per Business Quant data.

Peer Comparison